Cognitive and Alzheimer's disease biomarker effects of oral nicotinamide riboside (NR) supplementation in older adults with subjective cognitive decline and mild cognitive impairment.
Wu CY, Kupferschmid AC, Chen L, McManus AJ, Kivisäkk P, Galler JA, Schwab NA, DesRuisseaux LA, Williams VJ, Gerber J, Riley M, Young C, Guzmán-Vélez E, Dodge HH, Tanzi RE, Singer CM, Arnold SE.
Wu CY, et al. Among authors: chen l.
Alzheimers Dement (N Y). 2025 Jan 15;11(1):e70023. doi: 10.1002/trc2.70023. eCollection 2025 Jan-Mar.
Alzheimers Dement (N Y). 2025.
PMID: 39817194
Free PMC article.